Skip to main content
Equibles

STIFEL FINANCIAL CORP

Position in ZYME — Zymeworks Inc.

CIK 720672 ST. LOUIS, MO
Back to ZYME Full portfolio

Position in ZYME

as of Jun 30, 2026 · filed Aug 12, 2026
Position Value
$2,018,373
+$96,403 QoQ
Shares Held
77,214
+0.6% QoQ
Ownership
0.109%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#65
of 202 holders
Holding Since
Dec 2022
15 quarters on record
Voting authority Sole 100% Shared 0% None 0%

Common Shares in ZYME Over Time

Shares Held

Position Value (USD)

Position in Biotechnology

Healthcare · as of Jun 30, 2026

STIFEL FINANCIAL CORP holds $538,947,950 across 105 Biotechnology names. ZYME ranks #34 (0.4% of the industry book) .

# Ticker Company Shares Value (USD) Open
1 BHVN
Biohaven Ltd.
 9,941,165 $147,924,534
2 VRTX
Vertex Pharmaceuticals Inc / Ma
 162,151 $80,545,262
3 MANE
Veradermics, Inc
 294,117 $36,158,743
4 JAZZ
Jazz Pharmaceuticals plc
 139,491 $33,613,146
5 REGN
Regeneron Pharmaceuticals, Inc.
 46,378 $28,918,535
6 OMER
Omeros Corp
 1,836,925 $17,469,155
7 NTLA
Intellia Therapeutics, Inc.
 1,014,387 $17,163,427
8 IONS
Ionis Pharmaceuticals Inc
 202,983 $16,094,521

All Filings in ZYME

Export CSV
15 filing rows on record
Report Date Value (USD) Shares
2026-06-30 $2,018,373 77,214
2026-03-31 $1,921,970 76,756
2025-12-31 $1,997,051 75,847
2025-09-30 $1,238,812 72,530
2025-06-30 $875,111 69,730
2025-03-31 $798,326 67,030
2024-12-31 $941,791 64,330
2024-09-30 $924,357 73,654
2024-06-30 $613,689 72,114
2024-03-31 $762,016 72,435
2023-12-31 $727,559 70,025
2023-09-30 $394,823 62,275
2023-06-30 $452,088 52,325
2023-03-31 $396,178 43,825
2022-12-31 $312,828 39,800